Committed to Cystic Fibrosis Research
With any cystic fibrosis program, building and maintaining strong relationships is critical. For this reason, we make a concerted effort to keep our cross-functional cystic fibrosis study teams together over the course of multiple studies—aiding development of our therapeutic indication expertise and strengthening our relationships with sites and key opinion leaders.
Why Choose Rho?
Rho understands what it takes to successfully execute cystic fibrosis studies. Not only have we conducted studies of both pulmonary and gastrointestinal outcomes through inpatient and outpatient studies, we also have a comprehensive understanding of the Cystic Fibrosis Foundation Therapy Development Network (CFF TDN) and their protocol assessment and feasibility process. We also have experience coordinating standard of care with study-specific procedures and assessments, interacting with multidisciplinary care teams, and working with the CFF TDN data safety monitoring board (DSMB).